SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-13-015573
Filing Date
2013-10-16
Accepted
2013-10-16 19:33:49
Documents
1
Period of Report
2013-10-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 42851
  Complete submission text file 0001179110-13-015573.txt   44318
Mailing Address 4140 DUBLIN BLVD STE 200 DUBLIN CA 94568
Business Address 4140 DUBLIN BLVD SUITE 200 DUBLIN CA 94568 9255600100
Astex Pharmaceuticals, Inc (Issuer) CIK: 0000919722 (see all company filings)

IRS No.: 911841574 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O THE CHANNEL GROUP LLC 200 EAST 66TH STREET (E-1607) NEW YORK NY 10021
Business Address
Goldberg Allan R (Reporting) CIK: 0001319793 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-27628 | Film No.: 131155047